Table 7: Use
of inotropic support and outcome in the two groups.
|
Variable |
Group
1 (control) N=25 |
Group
2 (Dexmedetomidine) N=25 |
|
No
inotropes (n) |
11 |
12 |
|
Dopamine/dobutamine
(n) |
7 |
5 |
|
Adrenaline
(n) |
1 |
2 |
|
Adrenaline
and dopamine (n) |
6 |
6 |
|
Stay
in ICU (days) |
3.08±0.64 |
3.36
±1.25 |
|
Patients
expired (n) |
0 |
1 |
|
IABP
(n) |
NIL |
1 |
P=NS.